Although the existence of the EGFR/Stat3/Smad7 axis in CRC is yet to be evaluated, it is reasonable to hypothesize that enhanced Smad7 expression in CRC relies, at least in part, on Stat3 functioning. This evidence concerns the gene STAT3 and colorectal carcinoma.